StockDuty ← Dashboard Aug 20, 2026 06:23 PM ET
SignalCorporate

Can Eli Lilly Catch Novo Nordisk in the Oral GLP-1 Race?

Oral GLP-1 race pits Eli Lilly against Novo Nordisk, signaling competitive catalyst.

What changed
Why it matters
Oral GLP-1 race pits Eli Lilly against Novo Nordisk, signaling competitive catalyst.
Sources
eodhd
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →STRATEGY EXPANDS STRC PREFERRED STOCK BUYBACK PROGRAM; SHARES DOWN - SEEKINGALPHA →